A patient is found to have a genetic deficiency in the biomarker CYP2C19. The provider recognizes that prescribing clopidogrel will increase the patient's risk for developing what serious conditions? (Select all that apply.)

Question

Quizplus · Accepted Answer

Clopidogrel is a prodrug that requires activation by the enzyme CYP2C19. A deficiency in CYP2C19 can lead to reduced activation of clopidogrel, resulting in decreased antiplatelet effects and an increased risk of thrombotic events such as myocardial infarction and stroke.

A Patient Is Found to Have a Genetic Deficiency in the Biomarker